TSN

Business profile & competitive position

Tyson Foods, Inc. operates in the Consumer Defensive sector, specifically the Agricultural Farm Products industry. It is one of the largest protein processors in the United States, producing, distributing, and marketing chicken, beef, pork, and prepared foods. Its business sits at the intersection of commodity agriculture, consumer packaged goods, and retail/foodservice distribution. As a protein giant, Tyson's economics are tied to live animal costs, processing capacity, and branded/prepared-foods pricing power.

The company's real financial returns, however, tell a story of limited pricing power at the consolidated level. The trailing net margin is just 1.0%, and return on equity is only 3.2%. A consumer-defensive name with single-digit ROE and razor-thin margins is generally not earning its cost of capital by a wide margin, which implies that the competitive moat is weaker than the company's scale might suggest. Scale helps on input sourcing and plant utilization, but it does not insulate Tyson from commodity-driven margin compression in beef and pork, or from private-label and retail competition in prepared foods. In other words, size provides operational leverage, not necessarily durable pricing power.

Financial posture

Tyson carries a market capitalization of $20.3 billion and trades at a P/E multiple of 34.2 as of the latest data. That valuation looks steep for a business earning a 1.0% net margin and a 3.2% ROE. Typically, a Consumer Defensive protein processor with those profitability metrics commands a much lower earnings multiple, so the current P/E appears to embed an expectation of meaningful margin recovery rather than current earnings power. The stock's beta of 0.38 indicates low sensitivity to broad market swings relative to the average stock, consistent with a defensive, food-oriented name, but it also means much of the day-to-day volatility is company- and sector-specific.

The 50-day EMA stands at $59.15, while the current price is $57.16, placing the stock below its near-term moving average. The RSI of 42.9 is neutral-to-soft, neither oversold nor overbought. The combination of a high P/E, weak margins, and sub-4% ROE frames Tyson as a turnaround and margin-recovery story rather than a high-quality compounder at today's price.

Macro & geopolitical exposure

As an Agricultural Farm Products company, Tyson is directly exposed to commodity input cycles, weather, feed costs, livestock supply, and protein demand elasticity. Beef and pork margin swings are especially sensitive to cattle and hog prices, herd sizes, and processing spreads. The company is also exposed to regulatory risk around animal welfare, environmental compliance, labor practices at processing plants, and food-safety standards. Trade policy matters because U.S. meat exports can be affected by tariffs and foreign import quotas, while grain and feed costs move with global agriculture markets. Currency fluctuations affect the competitiveness of exported protein, and supply-chain disruptions can pressure plant throughput and refrigerated logistics costs. Inflation and consumer trade-down behavior also influence volume demand, particularly in the retail channel where private-label and value proteins can steal share.

Recent developments

Recent headlines have centered on Tyson's balancing act between improving chicken performance and worsening beef economics. On August 10, 2026, the company announced debt tender offers, according to GlobeNewswire, a move that suggests management is actively managing the balance sheet and refinancing liabilities. Earlier that week, Zacks published multiple notes flagging the cross-currents in Tyson's operations. On August 7, 2026, Zacks asked whether Tyson is worth buying as chicken strength battles beef margin risk—an exact reflection of the margin split the company is navigating. The same day, Zacks reported that Tyson cut its beef outlook as third-quarter volume slumped, and warned that beef losses are still widening. Another August 7 Zacks article noted Tyson shares had dropped 12.2% over the preceding three months, underscoring how the market has been repricing the stock around protein segment weakness.

Earnings behavior & post-earnings drift

Tyson has posted strong headline earnings performance: over the last eight reported quarters, it beat earnings estimates in seven of them, for an 88% beat rate, with an average surprise of 17.5%. Yet the post-earnings price reaction has not rewarded that consistency. Across those same quarters, the average 5-day move after earnings was -2.13%, classified as a downward drift. That disconnect is the central lesson for anyone analyzing TSN around releases: beating estimates has not reliably produced a sustained upward price move.

The last four quarters illustrate the pattern clearly. For the quarter reported August 3, 2026, Tyson earned $0.99 per share against an estimate of $0.989, essentially a 0.1% surprise beat, but the stock fell 1.46% the next day and 4.11% over the following five days. On May 4, 2026, the company beat by 11.5% with EPS of $0.87 versus $0.78 estimated, yet the stock slipped 0.45% the next day and 2.43% over five days. The February 2, 2026 miss—actual $0.97 versus $1.01 estimated, a -4% surprise—led to a 1.49% next-day drop and a 0.52% five-day decline. Even the November 10, 2025 quarter, where Tyson crushed estimates by 36.9% with $1.15 versus $0.84, saw the stock rise 2.99% the next day but then give back 1.47% over the following five sessions.

What this suggests is that the unofficial consensus—the market's real expectation—may be running ahead of the published analyst estimate, or that forward guidance and segment commentary are overpowering the backward-looking beat. Beats have been met with selling, guidance revisions, or sector repositioning, which is why disciplined post-earnings analysis for TSN requires looking beyond the binary beat/miss result. The next scheduled release is November 9, 2026 before the open, with the consensus EPS estimate at $1.09. Traders and investors watching that report should weigh not only whether Tyson clears $1.09, but what the beef and chicken segment commentary implies for the following quarters.

For a deeper look at how sell-side and institutional models are currently positioned on Tyson Foods, including detailed forward estimates and recommendation distributions, see the full institutional verdict on the ticker page.